CAPTION SCORE monitoring 2016 Graphs represent drug...

12
CAPTION SCORE monitoring 2016 Graphs represent drug residue loads in wastewater in [mg 1000p -1 d -1 ]. Samples were collected over a one-week period in spring of each year. font on x-axis bold = cities that participated in all six years. These values were considered for the calculation of a population- weighted average (dotted line across the graph) italic = cities with unexpected high or low values in at least one year (not used for any calculation of overall averages) dotted lines population-weighted average for cities that participated in all six years (bold font on x-axis) dashed lines in right margin population-weighted overall average for cities that participated in an individual year (without cities in italic font on x-axis) numbers in brackets rank averaged over all years of participation, please note: rank is not meaningful for cities where values were consistently <LOQ <LOQ concentration values in all seven samples were below limit of quantification fill color of dots white: all concentration values were >LOQ; grey: one or more values were <LOQ and replaced with 0.5xLOQ (the darker the more values were <LOQ) no dot not participated or substance not analyzed note Reykjavik participated 2016 with two STPs (2015 only one). Munich participated 2016 with two STPs (2015 only one, Munich=München Grosslappen, Munich_M=München Marienhof) Further cities with multiple STPs: Antwerp, Bratislava and Valencia (if only one value is plotted in the graph, then there are no substantial differences among the individual STPs in the same city). Acknowledgements These results are based upon work from COST Action ES1307, supported by COST (European Cooperation in Science and Technology) and EMCDDA (European Monitoring Centre for Drugs and Drug Addiction, where these results are accessible in an interactive map). COST (European Cooperation in Science and Technology) is a pan-European intergovernmental framework. Its mission is to enable break-through scientific and technological developments leading to new concepts and products and thereby contribute to strengthening Europe’s research and innovation capacities. www.cost.eu.

Transcript of CAPTION SCORE monitoring 2016 Graphs represent drug...

Page 1: CAPTION SCORE monitoring 2016 Graphs represent drug ...score-cost.eu/wp-content/uploads/sites/118/2016/02/SCORE... · 0 200 400 600 800 1000 BE loads [mg/1000p/d] BENZOYLECGONINE

CAPTION SCORE monitoring 2016

Graphs represent drug residue loads in wastewater in [mg 1000p-1 d-1].

Samples were collected over a one-week period in spring of each year.

font on x-axis

bold = cities that participated in all six years. These values were considered for the calculation of a population-

weighted average (dotted line across the graph)

italic = cities with unexpected high or low values in at least one year (not used for any calculation of overall

averages)

dotted lines

population-weighted average for cities that participated in all six years (bold font on x-axis)

dashed lines in right margin

population-weighted overall average for cities that participated in an individual year (without cities in italic font

on x-axis)

numbers in brackets

rank averaged over all years of participation, please note: rank is not meaningful for cities where values were

consistently <LOQ

<LOQ

concentration values in all seven samples were below limit of quantification

fill color of dots

white: all concentration values were >LOQ; grey: one or more values were <LOQ and replaced with 0.5xLOQ

(the darker the more values were <LOQ)

no dot

not participated or substance not analyzed

note

Reykjavik participated 2016 with two STPs (2015 only one).

Munich participated 2016 with two STPs (2015 only one, Munich=München Grosslappen, Munich_M=München

Marienhof)

Further cities with multiple STPs: Antwerp, Bratislava and Valencia (if only one value is plotted in the graph,

then there are no substantial differences among the individual STPs in the same city).

Acknowledgements

These results are based upon work from COST Action ES1307, supported by COST (European Cooperation in

Science and Technology) and EMCDDA (European Monitoring Centre for Drugs and Drug Addiction, where

these results are accessible in an interactive map).

COST (European Cooperation in Science and Technology) is a pan-European intergovernmental framework. Its

mission is to enable break-through scientific and technological developments leading to new concepts and

products and thereby contribute to strengthening Europe’s research and innovation capacities. www.cost.eu.

Page 2: CAPTION SCORE monitoring 2016 Graphs represent drug ...score-cost.eu/wp-content/uploads/sites/118/2016/02/SCORE... · 0 200 400 600 800 1000 BE loads [mg/1000p/d] BENZOYLECGONINE

LEYENDA - SCORE monitoring 2016

Los gráficos presentan la carga de residuos de drogas estupefacientes presentes en las muestras de

agua residual, expresada en miligramos por día por 1000 habitantes [mg 1000p-1 d-1].

Las muestras se tomaron cada año en primavera a lo largo de una semana.

Fuente del eje x

Negrita = ciudades que participaron en el estudio los seis años que éste se ha llevado a cabo, y cuyos valores se

utilizaron para calcular la carga media ponderada en función de la población (líneas de puntos en los gráficos)

Cursiva = ciudades que presentaron valores inesperadamente altos o bajos en al menos uno de los años de

estudio (valores no utilizados en el cálculo de cargas media totales)

Líneas de puntos

Carga media ponderada en función de la población calculada a partir de los valores encontrados en las

ciudades que participaron en el estudio los seis años que éste se ha llevado a cabo (indicadas en negrita en el

eje x)

Líneas discontinuas en el lado derecho del gráfico

Carga media ponderada en función de la población calculada a partir de los valores encontrados en todas las

ciudades participantes en un año específico (sin considerar los valores de las ciudades indicadas en cursiva en

el eje x)

Números en paréntesis

Rango (clasificación) de la ciudad en función de la carga promedio de drogas estupefacientes encontrada en el

agua residual en los años de estudio: este rango no es significativo para aquellas ciudades en las que la

concentración de una droga en particular se encontró de forma consistente por debajo del límite de

cuantificación (<LOQ)

<LOQ

Valores de concentración <LOQ en las siete muestras analizadas cada año.

Color de relleno de los símbolos

Blanco: todos los valores de concentración se encontraron >LOQ; escala de grises: uno o más valores de

concentración se encontraron <LOQ y en ese caso se sustituyeron por la mitad del valor del límite de

cuantificación (0.5xLOQ) (un tono de gris más oscuro indica un mayor número de valores <LOQ).

Ausencia de símbolo

Indica que ese año la ciudad no participó en el estudio o que la sustancia no fue analizada.

Agradecimientos

Estos resultados se basan en el trabajo realizado bajo la Acción COST ES1307, apoyada por COST (Cooperación

Europea en Ciencia y Tecnología) y EMCDDA (Centro Europeo de Monitorización de Drogas y Adicciones),

donde se puede acceder a estos resultados mediante un mapa interactivo).

COST es una marco intergubernamental para la cooperación europea en ciencia y tecnología. Su objetivo es

facilitar avances científicos y tecnológicos innovadores que generen nuevos conceptos y productos y así,

contribuir a fortalecer las capacidades de investigación e innovación de Europa. www.cost.eu.

Page 3: CAPTION SCORE monitoring 2016 Graphs represent drug ...score-cost.eu/wp-content/uploads/sites/118/2016/02/SCORE... · 0 200 400 600 800 1000 BE loads [mg/1000p/d] BENZOYLECGONINE

Legende SCORE Monitoring 2016

Drogenfrachten im Abwasser normiert pro 1000 Einwohner und Tag [mg 1000p-1 d-1] untersucht

über den Zeitraum einer Woche jeweils im Frühjahr.

Schriftart x-Achse

fett = hat in allen sechs Jahren teilgenommen und wurde für die Berechnung des Gesamtdurchschnittes

verwendet (gepunktete Linie)

kursiv = zeigt unerwartet hohen/tiefen Wert in mindestens einem Jahr (nicht verwendet für

Gesamtdurchschnitt)

Gepunktete Linien

bevölkerungsgewichteter Durchschnitt der Städte die alle sechs Jahre mitgemacht hatten (Schriftart fett).

Gestrichelte Linien am Rand

bevölkerungsgewichteter Durchschnitt der Städte die in Jahr x teilgenommen hatten und auf der Grafik

dargestellt sind (ohne die Städte in kursiver Schrift)

Zahlen in Klammern

Rang gemittelt für die Stadt gemittelt über alle Jahre (unabhängig von der Anzahl teilgenommenen Jahre;

beachte: Rang ist nicht sinnvoll für Städte wo der Wert immer <LOQ war))

<LOQ

Konzentrationen waren in allen 7 Proben unter der Quantifizierungsgrenze

Füllfarbe der Punkte

Weiss: alle Konzentrationswerte waren >LOQ; Grauwert: einer oder mehrere Werte waren <LOQ und sind mit

0.5xLOQ ersetzt worden (je dunkler desto mehr Werte waren <LOQ)

Kein Punkt

nicht teilgenommen oder Substanz nicht analysiert

Anmerkung

Reykjavik nahm 2016 mit zwei Kläranlagen teil (2015 nur eine).

München nahm 2016 mit zwei Kläranlagen teil (2015 nur eine, Munich=München Grosslappen,

Munich_M=München Marienhof)

Weitere Städte mit mehreren Kläranlagen: Antwerp, Bratislava und Valencia (wenn nur ein Wert in Grafik

erscheint, dann gibt es keine grossen Unterschiede zwischen den einzelnen Kläranlagen in der gleichen Stadt).

Acknowledgements

These results are based upon work from COST Action ES1307, supported by COST (European Cooperation in

Science and Technology) and EMCDDA (European Monitoring Centre for Drugs and Drug Addiction, where

these results are accessible in an interactive map).

COST (European Cooperation in Science and Technology) is a pan-European intergovernmental framework. Its

mission is to enable break-through scientific and technological developments leading to new concepts and

products and thereby contribute to strengthening Europe’s research and innovation capacities. www.cost.eu.

Page 4: CAPTION SCORE monitoring 2016 Graphs represent drug ...score-cost.eu/wp-content/uploads/sites/118/2016/02/SCORE... · 0 200 400 600 800 1000 BE loads [mg/1000p/d] BENZOYLECGONINE

LEGENDE|SCOREmonitoring2016

Lesgraphiquesillustrentleschargesenrésidusdeproduitsstupéfiantsdétectésdansleseauxusées.Ceschargessontindiquéesenmilligrammeparjouretpour1000habitants[mg·1000p-1·d-1].Ellesontétémesuréessurlabased’échantillonscollectéssuruneduréed’unesemaineauprintempsdechaqueannée.

Caractèresdel’axex

gras=villesquiontparticipéàl’ensembledessixannéesdemesure.Cesvaleursontservidebaseaucalculd’unemoyennepondéréeenfonctiondelapopulation(lignepointilléetraversantlegraphique).

italique=villesavecdesmesuresinattendues(bassesouhautes)pouraumoinsunedesannées(valeursnonutiliséespourlescalculsdevaleursmoyennes).

Lignespointillées

Moyennepondéréeenfonctiondelapopulationpourlesvillesquiontparticipéàl’ensembledessixannéesdemesure(indiquéesencaractèresgrassurl’axex).

Lignestraitilléesdanslamargededroite

Moyennepondéréeenfonctiondelapopulationpourlesvillesquiontparticipépourunecampagneannuelledemesure(sanslesvillesindiquéesencaractèresitaliquessurl’axex).

Nombresentreparenthèses

Rangétablisurlabasedelamoyennedel’ensembledesannéesdeparticipation(indépendammentdunombredeparticipations).Remarque:lerangn’estpassignificatifpourlesvillesdontlesvaleursmesuréessontconstamment<LOQ).

<LOQ

Valeursdeconcentrationinférieuresàlalimitedequantificationpourl’ensembledesseptéchantillons.

Couleurderemplissagedespoints

Blanc:touteslesconcentrationsmesuréessont>LOQ;gris:uneouplusieursvaleursest<LOQetaétéremplacéepar0.5xLOQ(pluslacouleurderemplissageestsombre,pluslenombredeconcentrations<LOQestimportant).

Absencedepoint

N’apasparticipéàlacampagnedemesure,oucettesubstancen’apasétémesurée.

Remerciements

L’obtentiondecesrésultatsestsoutenueparlaCOSTActionES1307(EuropeanCooperationinScienceandTechnology)etparl’EMCDDA(EuropeanMonitoringCentreforDrugsandDrugAddiction,quidiffuselesrésultatssousuneformeinteractive).

COST(EuropeanCooperationinScienceandTechnology)estunprogramme-cadreeuropéenquifavoriselarecherchecollaborativetransnationale.Samissionviseàpromouvoirlesdéveloppementsscientifiquesettechnologiquesdepointe,ainsiquel’émergencedenouveauxconceptsetproduits,dansuneperspectivederenforcementdescompétencesderechercheetd’innovationenEurope.www.cost.eu.

Page 5: CAPTION SCORE monitoring 2016 Graphs represent drug ...score-cost.eu/wp-content/uploads/sites/118/2016/02/SCORE... · 0 200 400 600 800 1000 BE loads [mg/1000p/d] BENZOYLECGONINE

0

200

400

600

800

1000

BE

load

s [m

g/10

00p/

d]

BENZOYLECGONINE (Cocaine)C

anbe

rra

Toow

oom

baG

ranb

yM

ontr

eal

Bog

ota

Med

ellin

Cop

enha

gen

Bus

anB

ende

rnM

alta

Auc

klan

dC

luj N

apoc

aB

elgr

ade

Nov

i Sad

Jyvä

skyl

äLa

ppee

nran

taO

ulu

Sav

onlin

naV

aasa

Joen

suu

Kuo

pio

Rov

anie

mi

Turk

uK

otka

Tam

pere

Laht

iE

spoo

Hel

sink

iK

rako

wP

ragu

eB

udw

eis

Tel−

Avi

vM

ytile

neT

hess

alon

iki

Ath

ens

Pie

stan

yB

ratis

lava

Sar

ajev

oN

icos

iaLi

mas

sol

Rey

kjav

ikO

slo

Alm

ada

Por

toLi

sbon

Got

henb

urg

Um

eåS

tock

holm

Ber

linD

resd

enD

ülm

enM

unic

h_M

Mun

ich

Dor

tmun

dK

lost

erne

ubur

gIn

nsbr

uck

Zag

reb

For

t−de

−F

ranc

e D

For

t−de

−F

ranc

e P

Par

isB

orde

aux

Mila

nS

eattl

eS

antia

goV

alen

cia

Cas

tello

nM

olin

a de

Seg

ura

Bar

celo

naA

mst

erda

mU

trec

htE

indh

oven B

iel

Chu

rLa

usan

neLu

zern

Neu

chat

elS

ion

Win

tert

hur

Ber

neLu

gano

Bas

elS

t.Gal

len

Gen

eva

Zur

ich

Ger

aard

sber

gen

Kok

sijd

eN

inov

eO

oste

nde

Ant

wer

p D

.B

russ

els

Ant

wer

p Z

.B

risto

lLo

ndon

AU CO KR MT RO FI CZ GR BA IS PT DE HR IT ES CH GBCA DK LI NZ RS PL IL SK CY NO SE AT FR US NL BE

max

=10

54m

ax=

1407

=10

95, m

ax=

1869

max

=12

59m

ax=

1145

●●

●●

●●

●●

● ●● ●●

●● ●●

●●

●●

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

2011 (Thomas et al. 2012)2012 (Ort and van Nuijs et al. 2014)2013 (Ort and van Nuijs et al. 2014)2014 (SCORE and associated partners*)2015 (SCORE and associated partners*)2016 (SCORE and associated partners*)

Page 6: CAPTION SCORE monitoring 2016 Graphs represent drug ...score-cost.eu/wp-content/uploads/sites/118/2016/02/SCORE... · 0 200 400 600 800 1000 BE loads [mg/1000p/d] BENZOYLECGONINE

0

20

40

60

80

100

120

MD

MA

load

s [m

g/10

00p/

d]

MDMAC

anbe

rra

Toow

oom

baG

ranb

yM

ontr

eal

Bog

ota

Med

ellin

Cop

enha

gen

Bus

anB

ende

rnM

alta

Auc

klan

dC

luj N

apoc

aB

elgr

ade

Nov

i Sad

Nic

osia

Lim

asso

lM

ytile

neT

hess

alon

iki

Ath

ens

Kra

kow

Mila

nS

eattl

eTe

l−A

viv

Alm

ada

Por

toLi

sbon

For

t−de

−F

ranc

e D

For

t−de

−F

ranc

e P

Bor

deau

xP

aris

Mol

ina

de S

egur

aS

antia

goC

aste

llon

Val

enci

aB

arce

lona

Joen

suu

Oul

uK

otka

Kuo

pio

Rov

anie

mi

Lapp

eenr

anta

Turk

uJy

väsk

ylä

Laht

iV

aasa

Sav

onlin

naTa

mpe

reE

spoo

Hel

sink

iP

iest

any

Bra

tisla

vaP

ragu

eB

udw

eis

Ber

linD

resd

enD

ülm

enD

ortm

und

Mun

ich_

MM

unic

hK

lost

erne

ubur

gIn

nsbr

uck

Sar

ajev

oB

iel

Chu

rLa

usan

neLu

zern

Neu

chat

elS

ion

Win

tert

hur

Luga

noB

erne

St.G

alle

nB

asel

Gen

eva

Zur

ich

Rey

kjav

ikG

othe

nbur

gU

meå

Sto

ckho

lmZ

agre

bLo

ndon

Bris

tol

Ger

aard

sber

gen

Kok

sijd

eN

inov

eO

oste

nde

Bru

ssel

sA

ntw

erp

D.

Ant

wer

p Z

.O

slo

Am

ster

dam

Utr

echt

Ein

dhov

en

AU CO KR MT RO CY PL US PT ES SK DE BA IS HR BE NLCA DK LI NZ RS GR IT IL FR FI CZ AT CH SE GB NO

max

=14

7m

ax=

182

max

=17

2m

ax=

143

max

=17

7

max

=13

9

max

=16

2

max

=17

0

max

=42

9

max

=14

2m

ax=

228

max

=14

5=

151,

max

=24

4=

166,

max

=31

8

=14

57, m

ax=

7260

=46

4, m

ax=

763

=92

96, m

ax=

4647

1=

131,

max

=36

5m

ax=

251

=61

5, m

ax=

1234

=16

2, m

ax=

371

max

=21

8m

ax=

154

max

=17

5m

ax=

157

● ●

●● ●

●●

●●

●●●

●●

● ●

●●

●●

● ●

● ●

●●

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

2011 (Thomas et al. 2012)2012 (Ort and van Nuijs et al. 2014)2013 (Ort and van Nuijs et al. 2014)2014 (SCORE and associated partners*)2015 (SCORE and associated partners*)2016 (SCORE and associated partners*)

Page 7: CAPTION SCORE monitoring 2016 Graphs represent drug ...score-cost.eu/wp-content/uploads/sites/118/2016/02/SCORE... · 0 200 400 600 800 1000 BE loads [mg/1000p/d] BENZOYLECGONINE

0

50

100

150

200

250

300

AM

P lo

ads

[mg/

1000

p/d]

AMPHETAMINEC

anbe

rra

Toow

oom

baG

ranb

yM

ontr

eal

Bog

ota

Med

ellin

Cop

enha

gen

Bor

deau

xF

ort−

de−

Fra

nce

DF

ort−

de−

Fra

nce

PP

aris

Mila

nB

usan

Ben

dern

Mal

taA

uckl

and

Clu

j Nap

oca

Bel

grad

eN

ovi S

adTe

l−A

viv

Alm

ada

Por

toLi

sbon

Myt

ilene

The

ssal

onik

iA

then

sN

icos

iaLi

mas

sol

Klo

ster

neub

urg

Inns

bruc

kP

ragu

eB

udw

eis

Bie

lC

hur

Laus

anne

Luga

noLu

zern

Neu

chat

elS

ion

Win

tert

hur

Gen

eva

Ber

neB

asel

St.G

alle

nZ

uric

hC

aste

llon

Mol

ina

de S

egur

aS

antia

goV

alen

cia

Bar

celo

naK

rako

wP

iest

any

Bra

tisla

vaS

avon

linna

Jyvä

skyl

äV

aasa

Joen

suu

Oul

uK

uopi

oLa

ppee

nran

taE

spoo

Turk

uR

ovan

iem

iTa

mpe

reK

otka

Hel

sink

iLa

hti

Sea

ttle

Zag

reb

Ber

linD

resd

enM

unic

h_M

Mun

ich

Dor

tmun

dD

ülm

enLo

ndon

Bris

tol

Ger

aard

sber

gen

Kok

sijd

eN

inov

eO

oste

nde

Bru

ssel

sA

ntw

erp

D.

Ant

wer

p Z

.O

slo

Rey

kjav

ikS

araj

evo

Got

henb

urg

Um

eåS

tock

holm

Am

ster

dam

Utr

echt

Ein

dhov

en

AU CO FR KR MT RO IL GR AT CH PL FI HR GB NO BA NLCA DK IT LI NZ RS PT CY CZ ES SK US DE BE IS SE

max

=31

9

max

=32

6

=30

40, m

ax=

9372

=41

7, m

ax=

864

=11

30, m

ax=

2460

max

=32

4=

607,

max

=21

17

=92

11, m

ax=

3284

4

●●

●●

● ●

●●

●●●

●●

●●

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

2011 (Thomas et al. 2012)2012 (Ort and van Nuijs et al. 2014)2013 (Ort and van Nuijs et al. 2014)2014 (SCORE and associated partners*)2015 (SCORE and associated partners*)2016 (SCORE and associated partners*)

Page 8: CAPTION SCORE monitoring 2016 Graphs represent drug ...score-cost.eu/wp-content/uploads/sites/118/2016/02/SCORE... · 0 200 400 600 800 1000 BE loads [mg/1000p/d] BENZOYLECGONINE

0

50

100

150

200

ME

TH

load

s [m

g/10

00p/

d]

METHAMPHETAMINEC

anbe

rra

Toow

oom

baS

araj

evo

Gra

nby

Mon

trea

lB

ogot

aM

edel

linC

open

hage

nB

orde

aux

For

t−de

−F

ranc

e D

For

t−de

−F

ranc

e P

Par

isB

risto

lLo

ndon

Zag

reb

Bus

anB

ende

rnM

alta

Auc

klan

dC

luj N

apoc

aB

elgr

ade

Nov

i Sad

Kra

kow

Lisb

onP

orto

Alm

ada

Klo

ster

neub

urg

Inns

bruc

kA

mst

erda

mU

trec

htE

indh

oven

Tel−

Avi

vM

ytile

neT

hess

alon

iki

Ath

ens

Ger

aard

sber

gen

Kok

sijd

eN

inov

eO

oste

nde

Ant

wer

p D

.B

russ

els

Ant

wer

p Z

.B

iel

Chu

rLa

usan

neLu

zern

Neu

chat

elS

ion

Win

tert

hur

Luga

noS

t.Gal

len

Gen

eva

Ber

neB

asel

Zur

ich

Rey

kjav

ikN

icos

iaLi

mas

sol

Cas

tello

nM

olin

a de

Seg

ura

San

tiago

Val

enci

aB

arce

lona

Mila

nG

othe

nbur

gU

meå

Sto

ckho

lmJo

ensu

uV

aasa

Lapp

eenr

anta

Laht

iTa

mpe

reR

ovan

iem

iK

otka

Oul

uS

avon

linna

Turk

uK

uopi

oJy

väsk

ylä

Hel

sink

iE

spoo

Ber

linD

ülm

enD

ortm

und

Mun

ich_

MM

unic

hD

resd

enO

slo

Pra

gue

Bud

wei

sS

eattl

eP

iest

any

Bra

tisla

va

AU CA DK GB KR MT RO PL AT IL BE IS ES SE DE CZ SKBA CO FR HR LI NZ RS PT NL GR CH CY IT FI NO US

=40

8, m

ax=

515

max

=33

7

max

=28

9

max

=25

3

=26

2, m

ax=

314

=32

7, m

ax=

351

=24

5, m

ax=

302

=23

7, m

ax=

292

max

=31

9

=67

2, m

ax=

805

=31

0, m

ax=

467

=30

8, m

ax=

337

=33

4, m

ax=

525

● ●●

●●

●●

●●

●●

●●

●●

●●

● ●●

●<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

2011 (Thomas et al. 2012)2012 (Ort and van Nuijs et al. 2014)2013 (Ort and van Nuijs et al. 2014)2014 (SCORE and associated partners*)2015 (SCORE and associated partners*)2016 (SCORE and associated partners*)

Page 9: CAPTION SCORE monitoring 2016 Graphs represent drug ...score-cost.eu/wp-content/uploads/sites/118/2016/02/SCORE... · 0 200 400 600 800 1000 BE loads [mg/1000p/d] BENZOYLECGONINE

0

50

100

150

200

TH

C−

CO

OH

load

s [m

g/10

00p/

d]

THC−COOH (Cannabis)In

nsbr

uck

Klo

ster

neub

urg

Can

berr

aTo

owoo

mba

Sar

ajev

oA

ntw

erp

D.

Ant

wer

p Z

.B

russ

els

Ger

aard

sber

gen

Kok

sijd

eN

inov

eO

oste

nde

Gra

nby

Mon

trea

lB

ogot

aM

edel

linN

icos

iaLi

mas

sol

Dor

tmun

dD

ülm

enD

resd

enM

unic

hM

unic

h_M

Ber

linC

open

hage

nE

spoo

Hel

sink

iJo

ensu

uJy

väsk

ylä

Kot

kaK

uopi

oLa

hti

Lapp

eenr

anta

Oul

uR

ovan

iem

iS

avon

linna

Tam

pere

Turk

uV

aasa

Bris

tol

Lond

onB

usan

Ben

dern

Mal

taA

uckl

and

Osl

oK

rako

wC

luj N

apoc

aB

elgr

ade

Nov

i Sad

Got

henb

urg

Sto

ckho

lmU

meå

Myt

ilene

The

ssal

onik

iA

then

sTe

l−A

viv

Pie

stan

yB

ratis

lava

Mila

nB

asel

Ber

ne Bie

lC

hur

Gen

eva

Laus

anne

Luze

rnN

euch

atel

Sio

nS

t.Gal

len

Win

tert

hur

Zur

ich

Luga

noA

lmad

aP

orto

Lisb

onR

eykj

avik

Pra

gue

Bud

wei

sZ

agre

bF

ort−

de−

Fra

nce

DF

ort−

de−

Fra

nce

PP

aris

Bor

deau

xM

olin

a de

Seg

ura

Val

enci

aS

antia

goC

aste

llon

Bar

celo

naA

mst

erda

mU

trec

htE

indh

oven

Sea

ttle

AT BA CA CY DK GB LI NZ PL RS GR SK CH IS HR ES USAU BE CO DE FI KR MT NO RO SE IL IT PT CZ FR NL

max

=31

9

=25

8, m

ax=

357

=34

6, m

ax=

403

max

=26

6m

ax=

383

max

=25

9

max

=31

3

=46

9, m

ax=

1016

max

=26

2

max

=34

8

=41

6, m

ax=

627

●●

●●

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

<LO

Q

2011 (Thomas et al. 2012)2012 (Ort and van Nuijs et al. 2014)2013 (Ort and van Nuijs et al. 2014)2014 (SCORE and associated partners*)2015 (SCORE and associated partners*)2016 (SCORE and associated partners*)

Page 10: CAPTION SCORE monitoring 2016 Graphs represent drug ...score-cost.eu/wp-content/uploads/sites/118/2016/02/SCORE... · 0 200 400 600 800 1000 BE loads [mg/1000p/d] BENZOYLECGONINE
Page 11: CAPTION SCORE monitoring 2016 Graphs represent drug ...score-cost.eu/wp-content/uploads/sites/118/2016/02/SCORE... · 0 200 400 600 800 1000 BE loads [mg/1000p/d] BENZOYLECGONINE
Page 12: CAPTION SCORE monitoring 2016 Graphs represent drug ...score-cost.eu/wp-content/uploads/sites/118/2016/02/SCORE... · 0 200 400 600 800 1000 BE loads [mg/1000p/d] BENZOYLECGONINE

Ant

wer

p Z.

(BE

)B

arce

lona

(ES

)C

aste

llon

(ES

)S

antia

go (E

S)

Hel

sink

i (FI

)Tu

rku

(FI)

Paris

(FR

)Za

greb

(HR

)M

ilan

(IT)

Ein

dhov

en (N

L)U

trech

t (N

L)O

slo

(NO

)A

ntw

erp

D. (

BE

)B

russ

els

(BE

)B

asel

(CH

)B

erne

(CH

)G

enev

a (C

H)

St.G

alle

n (C

H)

Zuric

h (C

H)

Bud

wei

s (C

Z)Va

lenc

ia (E

S)

Lond

on (G

B)

Am

ster

dam

(NL)

Dor

tmun

d (D

E)

Dre

sden

(DE

)D

ülm

en (D

E)

Ath

ens

(GR

)G

eraa

rdsb

erge

n (B

E)

Nin

ove

(BE

)Lu

gano

(CH

)Li

mas

sol (

CY

)N

icos

ia (C

Y)

Mun

ich

(DE

)C

open

hage

n (D

K)

Esp

oo (F

I)Ta

mpe

re (F

I)B

risto

l (G

B)

Alm

ada

(PT)

Lisb

on (P

T)U

meå

(SE

)B

ratis

lava

(SK

)P

iest

any

(SK

)C

anbe

rra (A

U)

Toow

oom

ba (A

U)

Sar

ajev

o (B

A)

Koks

ijde

(BE

)G

ranb

y (C

A)

Mon

treal

(CA

)C

hur (

CH

)La

usan

ne (C

H)

Luze

rn (C

H)

Neu

chat

el (C

H)

Sio

n (C

H)

Win

terth

ur (C

H)

Pra

gue

(CZ)

Ber

lin (D

E)

Mol

ina

de S

egur

a (E

S)

Joen

suu

(FI)

Jyvä

skyl

ä (F

I)Ko

tka

(FI)

Kuop

io (F

I)La

hti (

FI)

Lapp

eenr

anta

(FI)

Oul

u (F

I)R

ovan

iem

i (FI

)S

avon

linna

(FI)

Vaas

a (F

I)Fo

rt−de−F

ranc

e P

(FR

)Th

essa

loni

ki (G

R)

Rey

kjav

ik (I

S)

Ben

dern

(LI)

Porto

(PT)

Got

henb

urg

(SE

)S

tock

holm

(SE

)S

eattl

e (U

S)

Inns

bruc

k (A

T)K

lost

erne

ubur

g (A

T)O

oste

nde

(BE

)B

iel (

CH

)B

ogot

a (C

O)

Med

ellin

(CO

)M

unic

h_M

(DE

)B

orde

aux

(FR

)Fo

rt−de−F

ranc

e D

(FR

)M

ytile

ne (G

R)

Tel−

Aviv

(IL)

Bus

an (K

R)

Mal

ta (M

T)Au

ckla

nd (N

Z)K

rako

w (P

L)C

luj N

apoc

a (R

O)

Bel

grad

e (R

S)

Nov

i Sad

(RS

)Pe

king

(CN

)Lu

xem

bour

g (L

U)

Pozn

an (P

L)S

inga

pore

(SG

)

0

1

2

3

4

5

6

times

par

ticip

ated

201620152014201320122011

2

3

4

5

1ILS only

core group lablab within country (today)new SCORE lab (2014-2016)depends on other lab with free capacity

city withlab status 2016 (may have been di�erent 2011-2015)